Quick Takeaways
- This page summarizes Jane Wright-Mitchell's Form 4 filing for Vaxcyte, Inc. (PCVX).
- 3 reported transactions and 1 derivative row are listed below.
- Filing timestamp: 16 Aug 2021, 16:31.
Jane Wright-Mitchell - 12 Aug 2021 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)
- Role
- General Counsel
- Signature
- /s/ Ron A. Metzger, Attorney-in-Fact
- Issuer symbol
- PCVX
- Transactions as of
- 12 Aug 2021
- Net transactions value
- -$239,700
- Form type
- 4
- Filing time
- 16 Aug 2021, 16:31:24 UTC
- Next filing
- 18 Aug 2021
- SEC
- View on sec.gov
Quoteable Key Fact
"Jane Wright-Mitchell filed Form 4 for Vaxcyte, Inc. (PCVX) on 16 Aug 2021."
What Changed
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: -$239,700.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Transactions Table
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PCVX | Common Stock | Options Exercise | $20,300 | +10,000 | +320% | $2.03* | 13,125 | 12 Aug 2021 | Direct | F1 |
| transaction | PCVX | Common Stock | Sale | $260,000 | -10,000 | -76% | $26.00 | 3,125 | 12 Aug 2021 | Direct | F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PCVX | Stock Option (right to buy) | Options Exercise | $0 | -10,000 | -5% | $0.000000 | 189,968 | 12 Aug 2021 | Common Stock | 10,000 | $2.03 | Direct | F3 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Includes 1,563 shares acquired under the Employment Stock Purchase Plan on May 17, 2021. |
| F2 | The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. |
| F3 | 1/4 of the shares subject to the option vested on January 7, 2020, and 1/48 of the shares vest monthly thereafter. |